Phase II study of belzutifan plus cabozantinib for previously treated advanced renal cell carcinoma (RCC): Update from cohort 2 of LITESPARK-003 D. F. McDermott,T. K. Choueiri,S. Tykodi,J. Merchan,A. Roy, R. Perini, D. Vickery, T. BauerANNALS OF ONCOLOGY(2022)引用 4|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要